Antiretrovirals have been available in Ghana since 2003 for HIV-1 positive pregnant women for prevention of mother-to-child transmission (PMTCT). Suboptimal responses to treatment observed post-PMTCT interventions necessitated the need to investigate the profile of viral mutations generated. This study investigated HIV-1 drug resistance profiles in mothers in selected centres in Ghana on treatment with a history of prophylaxis.
Genotypic Drug Resistance Testing for HIV-1 was carried out. Subtyping was done by phylogenetic analysis and Stanford HIV Database programme was used for drug resistance analysis and interpretation. To compare the significance between the different groups and the emergence of drug resistance mutations, p values were used.
Participants who had prophylaxis before treatment, those who had treatment without prophylaxis and those yet to initiate PMTCT showed 32% (8), 5% (3) and 15% (4) HIV-1 drug resistance associated mutations respectively. The differences were significant with p value < 0.05. Resistance Associated Mutations (RAMs) were seen in 14 participants (35%) to nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). The most common NRTI mutation found was M184 V; K103 N and A98G were the most common NNRTI mutations seen. Thymidine Analogue Mutations (TAMs) such as M41 L, K70R and T215Y were found in all the groups; the most common of the TAMs found were M41 L and T215Y. Majority of the subtypes were CRF02_AG (82%).
In Ghana initiation of uninterrupted treatment upon diagnosis, coupled with drug resistance testing, would produce a better treatment outcome for HIV-1 positive pregnant women.
Ghana Health Service. Guidelines for Antiretroviral Therapy in Ghana, 2008.National HIV/AIDS/STI control Programme, Ministry of Health/Ghana health service. 2008.
Ghana Health Service. Guidelines for Antiretroviral Therapy in Ghana, 2011. National HIV/AIDS/STI Control Programme, Ministry of Health/Ghana Health Service, 2011.
Clavel F, Hance AJ. HIV drug resistance. N Engl J Med. 2004;350(10):1023–35. CrossRef
Handbook, QIAGEN One-Step RT-PCR Reagents, 2010.
Fujisaki S, Ibe S, Asagi T, Itoh T, Yoshida S. Performance and quality Assurance of Genotypic Drug Resistant Testing for human immunodeficiency virus type 1 in Japan. Jpn J Infect Dis. 2007;60:113–7. PubMed
Villahermosa ML, Thomson M, Vazquez de Parga E, Cuevas MT, Contreras G, Pérez-Alvarez L et al. improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load . J.Hum Virol 2000; 3(1): 27–34.
Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW et al. Update of the Drug Resistance Mutations in HIV-1: March 2013. Top Antivir Med .2013; 21(1):6–14. 2013 IAS-USA.
Zhang Z, Schwartz S, Wagner L, Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol. 2000;7(1–2):203–14. CrossRef
Morgulis A, Coulouris G, Raytselis Y, Madden TL, Agarwala R, Schäffer AA. Database indexing for production MegaBLAST searches. Bioinformatics. 2008;24:1757–64. CrossRef
Thompson JD, Higgins DG, Gibson TJ. Clustal W: improving the sensitivity of progressive multiple alignments through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673–380. CrossRef
Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucl Acids Symp 1999; Ser 41:95–98.
Tamura K, Stetcher G, Peterson D, Filipski A, Kumar S. MEGA 6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. CrossRef
Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376:49–62. CrossRef
Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related millennium development goals: time for a public health approach. Lancet. 2011;378:282–4. CrossRef
World Health Organization. Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015.
Whitcomb JM, Parkin NT, Chappey C, Hellman NS, Petropoulos CJ. Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates. J Infect Dis. 2003;188(7):992–1000. CrossRef
Virco Interactive HIV Resistance Learning Module (2006). Available at: http://www.vircolab.com/hiv-educational-forum/hivaids-learning modules.
Stanford University HIV Drug resistance database, 2011. HIVdb: Genotypic Resistance Interpretation Algorithm; ( www.hivdb.stanford.edu).
World Health Organization Programmatic Update 2012.Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2012.
National AIDS/STIs Control Programme (NACP) Quarterly Technical Bulletin on HIV/AIDS-STI in Ghana, Vol 9: No.1 January, 2012.
Sagoe KWC, Dwidar M, Lartey M, Boamah I, Agyei AA, Arens MQ, et al. Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naïve patients in Accra, Ghana. J Clin Virol. 2007;40(2):163–7. CrossRef
Brandful JA, Coetzer ME, Cilliers T, Phoswa M, Papathanasopoulos MA, Morris L, et al. Phenotypic characterization of HIV type 1 isolates from Ghana. AIDS Res Hum Retrov. 2007;23(1):144–52. CrossRef
Fischetti L, Opare-Sem O, Candotti D, Sarkodie F, Lee H, Allain JP. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J Med Virol. 2004;73(2):158–66. CrossRef
Delgado E, Ampofo WK, Sierra M, Torpey K, Pérez-Alvarez L, Bonney EY. High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study. J Acquir Immune Defic Syndr. 2008;48(5):599–606. CrossRef
Ghana Health Service. Guidelines for Antiretroviral Therapy in Ghana, 2016. National HIV/AIDS/STI Control Programme, Ministry of Health/Ghana Health Service, September, 2016.
- Emergence of HIV-1 drug resistance mutations in mothers on treatment with a history of prophylaxis in Ghana
Charles Addoquaye Brown
John Kofi Odoom
Evelyn Yayra Bonney
Nana Afia Asante Ntim
Kwamena William Sagoe
William Kwabena Ampofo
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II